🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will look at your body's response to the new immunizations. We w...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-07-10
Trial ID
NCT00505063
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
A Study comparing three different doses of ProQuad to concomitant administr...
Status
Completed
Location
Multiple Locations
Start Date
1999-04
Trial ID
NCT00986232
The current recommendation for a full course of measles-mumps-rubella-(vari...
Status
Recruiting
Location
University of Alberta
Start Date
2024-11-09
Trial ID
NCT05923970
The purpose of this study is to determine immune system function following ...
Status
Completed
Location
UAB, Dept. of Ped., Div. of Infectious Diseases
Start Date
2006-02
Trial ID
NCT00257127
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400013
Start Date
2025-02-18
Trial ID
NCT06824194
The purpose of this study is to demonstrate, in 12-23 month old children, t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-05
Trial ID
NCT00474266
Treatments Being Tested
The primary objective of this study was to describe the safety profile of M...
Status
Completed
Location
Birmingham Pediatric Associates-Site Number:8400049
Start Date
2018-09-17
Trial ID
NCT03673462
Treatments Being Tested
This study aims to assess the immune response and safety of GSK's candidate...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-04-17
Trial ID
NCT06855160
The aim of the study was to assess whether the second CYD dengue vaccinatio...
Status
Completed
Location
Multiple Locations
Start Date
2011-07-18
Trial ID
NCT01411241
Treatments Being Tested